Latest articles:

OXiGENE signs definitive agreement to sell Common Stock
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has entered into a definitive agreement with certain institutional investors to sell 6,578,945 shares of its Common Stock and separate series of warrants to purchase Common Stock in a

PSA test is still the best option for diagnosing prostate cancer
When it comes to the documented 40 percent effectiveness of PSA testing in preventing death from prostate cancer, neither the American Cancer Society nor the discoverer of the PSA protein, Richard Ablin, are telling the public the complete story.

Researchers identify novel cellular mechanism that may aid in developing new strategies for cancer treatment
A research team led by the University of Colorado at Boulder has discovered a previously unknown cellular "switch" that may provide researchers with a new means of triggering programmed cell death, findings with implications for treating cancer.

Survey: Employers plan to shift more health costs to workers
The Washington Post: "Most big employers plan to shift a larger share of health-care costs to their workers next year, according to a survey to be released Thursday. ... Meanwhile, employees at many companies can expect significantly higher premiums, deductibles and co-payments, according to the annual survey by

Study explores incidence of eating disorders among type 1 diabetic patients
Diabetics, under the gun to better manage their disease by controlling their food intake and weight, may find themselves in the sticky wicket of needing treatment that makes them hungry, researchers said.

FDA warns healthcare professionals about bogus surgical mesh products
The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists.

AIDS 2010 to highlight epidemic in Eastern Europe, Central Asia regions
AIDS 2010, the International AIDS Conference to be held July 18-23 in Vienna, Austria, will "highlight the situation in Eastern Europe and Central Asia, regions experiencing fast growing [HIV/AIDS] epidemics largely through unsafe injecting drug use," conference organizers announced Wednesday, Agence France-Presse reports.

Intel, Mayo Clinic and GE launch new initiative to study care and benefits of home-based telemedicine
Emerging Healthcare Solutions, Inc. was pleased on learning the news that Intel, The Mayo Clinic and GE Healthcare have launched a new initiative to study the care and cost benefits of home-based telemedicine for elderly patients with chronic illnesses.

Age-related macular degeneration affects central vision in older Americans
Indianapolis resident Harry Traugott was an active retiree, participating in community events, driving and even teaching English as a second language at two community centers.

He’d been diagnosed with age-related macular degeneration (AMD), but the disease had not caused significant vision loss. It wasn’t until he had

NHS to improve response to violence against women and children
The role of the NHS in responding to violence against women and children is the subject of a new report by an independent taskforce of experts including Gene Feder, Professor of Primary Health Care at the University of Bristol.

Latest Searches: knee buckling, keynet com pl, kiliclub com, t971t, kz templates, krovatka su, preparing, hemosis, kroll gmbh, keynet com, mevacor, ectasy, esnips com user mobile razr ringtone j, syndromes, warnings, krovatka. Top Searches...